Strikingly, despite increased sensitivity to MCL1 inhibition, PBRM1 mutant ccRCC cell lines had lower endogenous levels of MCL1 (Supplementary Figure S2A). The gene discussed is PBRM1; the disease is nonpapillary renal cell carcinoma.